Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02101775 |
|---|---|
| Brief Title: | Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
| First Submitted : | March 28, 2014 |
| First Submitted that Met QC Criteria : | March 28, 2014 |
| First Posted : | April 2, 2014 (Estimate) |
| Results First Submitted : | March 21, 2023 |
| Results First Submitted that Met QC Criteria : | September 6, 2023 |
| Results First Posted : | September 8, 2023 |
| Last Update Submitted that Met QC Criteria : | March 7, 2024 |
| Last Update Posted : | March 8, 2024 |